Fennec Expects U.S. FDA to Decline Application for Hearing Loss Drug Post author By Post date November 29, 2021 Fennec Pharmaceuticals Inc said Read MoreShare this:TwitterFacebookLike Loading... Related Tags analysis, business, business news, economy, economy news, finance, market analysis, market research, markets, news, world news ← Brazilβs Azul Confirms LATAM M&A Offer, but Backs Off as Valuation Too High → Swiss Franc Rises to Six Year High as Central Bank Stands Back